ClinicalTrials.Veeva

Menu

Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy

Florida State University logo

Florida State University

Status and phase

Completed
Phase 1

Conditions

Chronic Pain
Opioid Abuse, Unspecified Use

Treatments

Behavioral: Conventional Support Group (SG)
Behavioral: Mindfulness-Oriented Recovery Enhancement

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01505101
R03DA032517 (U.S. NIH Grant/Contract)
DA032517-01

Details and patient eligibility

About

Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions have been shown reduce chronic pain symptoms, addictive processes, and substance use. The investigators hypothesize that relative to a support group control condition, participation in a novel mindfulness-oriented cognitive intervention, Mindfulness-Oriented Recovery Enhancement (MORE), will result in improved well-being and decreased pain, opioid craving, and opioid misuse behaviors among chronic pain patients receiving opioid therapy.

Full description

Few behavioral treatments target the cognitive-affective mediators of opioid misuse and addiction in chronic pain patients. As such, novel, multimodal interventions are needed to effectively target key mechanisms in the risk chain from chronic pain to opioid misuse and addiction. The secondary aim of this study is to explore possible cognitive, affective, and psychophysiological mediators of intervention effects on pain, opioid craving, opioid misuse behaviors, and well-being.

Enrollment

115 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic pain diagnosis (ICD-9 diagnoses 338.xx)
  • treatment with prescription opioids for > 3 months

Exclusion criteria

  • prior mindfulness training
  • persons who are experiencing acute opioid withdrawal
  • suicidal ideation
  • psychosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

115 participants in 2 patient groups

Mindfulness-Oriented Recovery Enhancement
Experimental group
Treatment:
Behavioral: Mindfulness-Oriented Recovery Enhancement
Conventional Support Group (SG)
Active Comparator group
Treatment:
Behavioral: Conventional Support Group (SG)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems